Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA).
J Med Chem
; 61(15): 6501-6517, 2018 Aug 09.
Article
in En
| MEDLINE
| ID: mdl-30044619
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Azo Compounds
/
Muscular Atrophy, Spinal
/
RNA Splicing
/
Survival of Motor Neuron 2 Protein
/
Drug Discovery
Limits:
Animals
/
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: